March 30, 2022 | 10 min. 21 sec. | Point du jour (Ici Radio-Canada) Interview (in French) with Maria Lily Shaw, Economist […]
March 29, 2022 | 12 min. 01 sec. | Richard Martineau (QUB Radio) Interview (in French) with Maria Lily Shaw, Economist at […]
À l’heure où le ministre de la Santé s’apprête à déposer son plan pour une refonte du système de santé, un élément incontournable s’impose: l’augmentation du nombre de médecins conjuguée à des mesures permettant une meilleure utilisation des ressources existantes.
We Canadians like to think we lead the world when it comes to health care. The facts, however, tell a different story.
Leading up to the 2022 federal budget, one of the hopes of the pharmaceutical sector is that the government will repeal and rethink certain regulatory updates to the Patented Medicine Prices Review Board.
On Tuesday, March 22, the Quebec government tabled its 2022-2023 provincial budget. In this publication, we note the significant growth in portfolio spending in recent decades, taking into account the newly-released numbers, and we use different scenarios to illustrate the magnitude of this increase.
March 21, 2022 | 29 min. 23 sec. | L’effet Normandeau (98,5 FM) Debate (in French) with Maria Lily Shaw, Economist at […]
The positive impacts of improving access to this drug have been evident in other provinces that have added the shingles vaccine to their provincial immunization programs.
It’s time to transform our monopolistic health care system into a mixed, universal system that embraces the value of parallel resources to improve both access and quality of care for patients.
As public health measures begin to ease across the country, provinces are relying on the availability of new oral medications meant to reduce the risk of COVID-19 induced hospitalizations to keep the strain on our health care system to a minimum.